AU5538794A - Biologically active compounds and process therefor - Google Patents

Biologically active compounds and process therefor

Info

Publication number
AU5538794A
AU5538794A AU55387/94A AU5538794A AU5538794A AU 5538794 A AU5538794 A AU 5538794A AU 55387/94 A AU55387/94 A AU 55387/94A AU 5538794 A AU5538794 A AU 5538794A AU 5538794 A AU5538794 A AU 5538794A
Authority
AU
Australia
Prior art keywords
biologically active
active compounds
process therefor
therefor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55387/94A
Inventor
Tesfaye Biftu
Yuan-Ching P Chiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/966,764 external-priority patent/US5256689A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU5538794A publication Critical patent/AU5538794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
AU55387/94A 1992-10-26 1993-10-22 Biologically active compounds and process therefor Abandoned AU5538794A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96697192A 1992-10-26 1992-10-26
US07/966,764 US5256689A (en) 1991-05-10 1992-10-26 Cholesterol lowering compounds
US966971 1992-10-26
US966764 1992-10-26
PCT/US1993/010164 WO1994009774A1 (en) 1992-10-26 1993-10-22 Biologically active compounds and process therefor

Publications (1)

Publication Number Publication Date
AU5538794A true AU5538794A (en) 1994-05-24

Family

ID=27130490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55387/94A Abandoned AU5538794A (en) 1992-10-26 1993-10-22 Biologically active compounds and process therefor

Country Status (2)

Country Link
AU (1) AU5538794A (en)
WO (1) WO1994009774A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016184A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Method and pharmaceutical composition for regulating lipid concentration
EP1340509A1 (en) * 1998-12-23 2003-09-03 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
US6489366B1 (en) 1998-12-23 2002-12-03 G. D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
DE69908644T2 (en) * 1998-12-23 2004-05-13 G.D. Searle Llc, Chicago COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND GALLIC ACID SEQUESTRING AGENTS FOR CARDIOVASCULAR INDICATIONS
EA200100707A1 (en) * 1998-12-23 2001-12-24 Джи.Ди.Сирл Ллс COMBINATIONS OF INHIBITORS OF TRANSPORT OF BILK ACIDS IN THE SUBJECTIVE AND FIBRIN ACID DERIVATIVES FOR THE CARDIOVASCULAR INDICATIONS
IL143944A0 (en) * 1998-12-23 2002-04-21 Searle Llc Combinations for cardiovascular indications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055487A (en) * 1990-03-21 1991-10-08 Merck & Co., Inc. Novel anti-fungal compounds

Also Published As

Publication number Publication date
WO1994009774A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU3751493A (en) Biological material
AU669350B2 (en) Electrode
AU4530993A (en) Leachate treatment system
AU3993993A (en) Microorganism growth apparatus
AU5428594A (en) Novel plants and processes for obtaining them
AU4109593A (en) Carbodiimides and processes therefor
AU6396490A (en) Nitroguanidine compounds and insecticides
AU6955594A (en) Aminoureaformaldehyde fertilizer method and composition
AU4579893A (en) Bone materials
EP0591807A3 (en) Biologically active polymers
AU656457B2 (en) Chemical process
AU2380595A (en) Biologically active composition
AU4520893A (en) Sterilization process and composition
AU4380593A (en) Reference electrode
HU9201911D0 (en) New biologically active eburnamine derivatives and method for producing them
AU3350293A (en) Process and device for exterminating microorganisms
AU3730093A (en) Methods of treating diabetes
AU5538794A (en) Biologically active compounds and process therefor
AU5666994A (en) T-configured wheelchair
AU3100793A (en) Chemical process
AU4314993A (en) Mixtures of active anti-microbial substances
AU1952292A (en) Applicator for biologically active substance
AU3200493A (en) Ganglioside-GM3-fortified nutrient composition
AU3380793A (en) Treatment of waste or other material
AU6582694A (en) Biologically active peptides